295
Inhibrx Biosciences, Inc.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
Assets
(positive)
Change from FY23 to FY25
millions USD
FY23:
FY24:
160
FY25:
133
(positive)
Change from FY23 to FY25
millions USD
FY23:
12.5
FY24:
20.4
FY25:
13.6
Total assets
Change from FY23 to FY25
millions USD
FY23:
308
FY24:
181
FY25:
146
Liabilities & Equity
(negative)
Change from FY23 to FY25
millions USD
FY23:
56.3
FY24:
40.7
FY25:
33.8
(negative)
Change from FY23 to FY25
millions USD
FY23:
208
FY24:
6.45
FY25:
105
(positive)
Change from FY23 to FY25
millions USD
FY23:
43.5
FY24:
134
FY25:
7.99
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY23:
308
FY24:
181
FY25:
146
All amounts in millions USD